Search

everythinglearnresearchcommunity

for

Search:↓

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

Mesenchymal stem cells show potential for skin healing and anti-aging, but more research is needed for safe use, especially regarding stem cells from induced pluripotent sources.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Low-level laser therapy using near-infrared light may help heart conditions and promote healing by releasing nitric oxide.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Light therapy might help treat hereditary hair loss by improving hair follicle growth in lab cultures.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Stem cell therapy is a promising approach for hair regrowth despite potential side effects.

PFS might be a delusional disorder with potential to become mass psychogenic illness.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Light therapy may improve eye conditions by stimulating cell activity and increasing oxygen availability.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

A new microneedle patch helps treat hair loss by improving drug delivery to hair follicles.

New techniques and findings in dermatologic surgery show improved pain management, safer liposuction, better hair transplantation, and effective treatments for skin conditions.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.